Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech

Turn Biotechnologies acquires drug delivery tech from Harvard & Vesigen Therapeutics to expand mRNA aging therapies; CEO Anja Krammer aims for 2026 clinical trialsRead More

What's Trending

AI staffers quit, issue warnings on way out

Local restaurants craft unique ways to brew up business in winter season

Mortgage rates edge lower, hover near 6%

US Statehouses Push Laws to Hinder Trump Immigration Enforcement

36-year-old left her law career to start a custom fine jewelry business—now it brings in 7 figures in yearly sales

FDA rejects Moderna’s mRNA flu vaccine application – for reasons with no basis in the law

Federal court strikes down Louisiana law on disabled veterans’ claims consultants

Governor Kay Ivey signs Child Predator Death Penalty Act into law

Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech

Big Tech’s data center push has sent electricity bills higher. Lawmakers want to slow them down.

No. 5 FSU vs. No. 1 Texas Tech softball: Live updates and highlights

Slashed Valuations, Postponed Deal Puncture US IPO Optimism

CBP shot down party balloons with anti-drone tech before FAA closed El Paso airspace, sources say

Leave A Reply Cancel Reply

What's Trending

Exclusive: mRNA startup Turn Biotechnologies acquires Vesigen’s microvesicle delivery tech

Related Posts

Leave A Reply Cancel Reply

Subscribe to MGSN